Abstract
CONTEXT:
Morbid obesity (body mass index (BMI) ≥40 kg/m2) is associated with substantially increased morbidity and mortality from chronic health conditions and with poorer health-related quality of life; however, less is known about the impact of morbid obesity on healthcare expenditures.
OBJECTIVE:
To examine the impact of morbid obesity on healthcare expenditures using a nationally representative sample of US adults.
DESIGN, SETTING, AND PARTICIPANTS:
We performed a cross-sectional analysis of 16 262 adults from the 2000 Medical Expenditure Panel Survey, a nationally representative survey of the noninstitutionalized civilian population of the United States. Per capita healthcare expenditures were calculated for National Institutes of Health BMI categories, based on self-reported height and weight, using a two-part, multivariable model adjusted for age, gender, race, income, education level, type of health insurance, marital status, and smoking status.
MAIN OUTCOME MEASURES:
Odds of incurring any healthcare expenditure and per capita healthcare expenditures associated with morbid obesity in 2000.
RESULTS:
When compared with normal-weight adults, the odds of incurring any healthcare expenditure in 2000 were two-fold greater among adults with morbid obesity. Per capita healthcare expenditures for morbidly obese adults were 81% (95% confidence interval (CI): 48–121%) greater than normal-weight adults, 65% (95% CI: 37–110%) greater than overweight adults, and 47% (95% CI: 11–96%) greater than adults with class I obesity. Excess costs among morbidly obese adults resulted from greater expenditures for office-based visits, outpatient hospital care, in-patient care, and prescription drugs. Aggregate US healthcare expenditures associated with excess body weight among morbidly obese US adults exceeded $11 billion in 2000.
CONCLUSIONS:
The economic burden of morbid obesity among US adults is substantial. Further research is needed to identify interventions to reduce the incidence and prevalence of morbid obesity and improve the health and economic outcomes of morbidly obese adults.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH . Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002; 288: 1758–1761.
Sturm R . Increases in clinically severe obesity in the United States, 1986–2000. Arch Intern Med 2003; 163: 2146–2148.
United States Census Bureau. Population estimates 2002.
Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW . Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999; 341: 1097–1105.
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH . The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523–1529.
Bianchini F, Kaaks R, Vainio H . Overweight, obesity, and cancer risk. Lancet Oncol 2002; 3: 565–574.
Huang Z, Willett WC, Manson JE, Rosner B, Stampfer MJ, Speizer FE, Colditz GA . Body weight, weight change, and risk for hypertension in women. Ann Intern Med 1998; 128: 81–88.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Ke Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–1350.
Sowers JR . Obesity as a cardiovascular risk factor. Am J Med 2003; 115 (Suppl 8A): 37S–41S.
Bocchieri LE, Meana M, Fisher BL . A review of psychosocial outcomes of surgery for morbid obesity. J Psychosom Res 2002; 52: 155–165.
Kolotkin RL, Crosby RD, Pendleton R, Strong M, Gress RE, Adams T . Health-related quality of life in patients seeking gastric bypass surgery vs non-treatment-seeking controls. Obes Surg 2003; 13: 371–377.
Finkelstein EA, Fiebelkorn IC, Wang G . National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff (Millwood) 2003; (Suppl); Jan–Jun, W3-219–W3-226.
Sturm R . The effects of obesity, smoking, and drinking on medical problems and costs. Obesity outranks both smoking and drinking in its deleterious effects on health and health costs. Health Aff (Millwood) 2002; 21: 245–253.
Finkelstein EA, Fiebelkorn IC, Wang G . State-level estimates of annual medical expenditures attributable to obesity. Obes Res 2004; 12: 18–24.
Sturm R, Ringel JS, Andreyeva T . Increasing obesity rates and disability trends. Health Aff (Millwood) 2004; 23: 199–205.
MEPS 2000 full year consolidated data file. In: Documentation for MEPS HC-050. Agency for Healthcare Research and Quality: Rockville, MD; June 2003.
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Government Printing Office: Washington, DC; 1998.
Diehr P, Yanez D, Ash A, Hornbrook M, Lin DY . Methods for analyzing health care utilization and costs. Annu Rev Public Health 1999; 20: 125–144.
Manning WG, Mullahy J . Estimating log models: to transform or not to transform? J Health Econ 2001; 20: 461–494.
Thompson D, Wolf AM . The medical-care cost burden of obesity. Obes Rev 2001; 2: 189–197.
Spencer EA, Appleby PN, Davey GK, Key TJ . Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 2002; 5: 561–565.
Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. Series 1: programs and collection procedures. US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics: Hyaftsville, MD; July 1994.
Wang G, Zheng ZJ, Heath G, Macera C, Pratt M, Buchner D . Economic burden of cardiovascular disease associated with excess body weight in US adults. Am J Prev Med 2002; 23: 1–6.
Rockhill B, Newman B, Weinberg C . Use and misuse of population attributable fractions. Am J Public Health 1998; 88: 15–19.
Clegg A, Colquitt J, Sidhu M, Royle P, Walker A . Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Relat Metab Disord 2003; 27: 1167–1177.
Craig BM, Tseng DS . Cost-effectiveness of gastric bypass for severe obesity. Am J Med 2002; 113: 491–498.
Roux L, Donaldson C . Economics and obesity: costing the problem or evaluating solutions? Obes Res 2004; 12: 173–179.
Bodenheimer T, Wagner EH, Grumbach K . Improving primary care for patients with chronic illness. JAMA 2002; 288: 1775–1779.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arterburn, D., Maciejewski, M. & Tsevat, J. Impact of morbid obesity on medical expenditures in adults. Int J Obes 29, 334–339 (2005). https://doi.org/10.1038/sj.ijo.0802896
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802896
Keywords
This article is cited by
-
Social costs of obesity in the Czech Republic
The European Journal of Health Economics (2023)
-
Impacts of bariatric surgery in health outcomes and health care costs in Brazil: Interrupted time series analysis of multi-panel data
BMC Health Services Research (2022)
-
Intragastric Balloon as Bridging Therapy Prior to Bariatric Surgery for Patients with Severe Obesity (BMI ≥ 50 kg/m2): a Systematic Review and Meta-analysis
Obesity Surgery (2022)
-
Towards Cost-Effective Care for Severe Obesity
Obesity Surgery (2022)
-
Health-Related Quality of Life in Bariatric and Metabolic Surgery
Current Obesity Reports (2020)